MYELOMA CANADA WELCOMES THREE NEW MEMBERS
TO THE BOARD OF DIRECTORS
To help guide the next phase of its development Myeloma Canada has expanded its Board of Directors. In addition to broadening geographic representation, the three new Board members bring valued experience and skills to complement those of the existing members. The group of highly experienced individuals who comprise the Board of Directors bring a wealth of diverse experience including medicine, research, law, accounting, finance, marketing, pharmacy, management, governance and business planning. Three of the eight Board members are patients, thereby ensuring that the important voice of the patient is strongly represented.
To help guide the direction of Myeloma Canada's programs and drive forward its mission of making myeloma matter, Myeloma Canada welcomes Dr Anthony Reiman, Anthony Everett and Harris Poulis to the Board of Directors.
Professor, Faculty of Medicine
Assistant Dean of Research
Dalhousie Medicine New Brunswick
Canadian Cancer Society Research Chair
University of New Brunswick and
Atlantic Cancer Research Institute
Saint John, New Brunswick
Anthony Everett
Consultant, Governance,
Business Planning and Marketing
Prince George, British Columbia
Harris Poulis
General Counsel and Director of Legal Affairs,
McGill University Health Centre
Montreal, Quebec
|
